Dexcom stock forecast 2025 for Dexcom stock forecast 2025

For Dexcom stock forecast 2025, competitive advantage stems from proprietary sensor technology and subscription-based revenue streams, which may secure double-digit valuation multiples. Roche RHHBY has maintained steady growth across its Diagnostics arm, achieving 6% sales growth in first quarter of 2025 on a constant-exchange-rate basis. Roche is advancing CGM technology, showcasing an AI-enabled SmartGuide system that predicts glucose trends and hypoglycemia up to two hours ahead. These innovations reinforce Roche’s potential to integrate predictive analytics into diabetes care and expand its CGM footprint. Sign up for free newsletters and get more CNBC delivered to your inbox Market sentiment for Dexcom stock forecast 2025 remains optimistic, fueled by rising global diabetes rates and increased CGM adoption, positioning DXCM among high-growth medical technology equities.